FDA bans sales of transvaginal mesh amid safety concerns

Transvaginal mesh has been used to treat pelvic floor disorders and incontinence in women.

(CNN)Manufacturers of surgical mesh products must stop selling and distributing their products in the United States immediately, the US Food and Drug Administration ordered Tuesday.

The FDA said it "has determined that the manufacturers, Boston Scientific and Coloplast, have not demonstrated a reasonable assurance of safety and effectiveness for these devices."
Each year, thousands of women undergo transvaginal surgery to repair pelvic organ prolapse, a condition where weakened muscles and ligaments cause the pelvic organs to drop lower in the pelvis, creating a bulge or prolapse in the vagina. In the 1990s, gynecologists began implanting surgical mesh for the transvaginal repair of the condition and in 2002, the first mesh device specifically for this purpose was cleared for use by the FDA, according to the agency's statement.
    "We couldn't assure women that these devices were safe and effective long term," said Dr. Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health.
    Women who have had transvaginal mesh surgically implanted should "continue with their annual and other routine check-ups and follow-up care," the FDA advised. "There is no need to take additional action if they are satisfied with their surgery and are not having complications or symptoms."
    Patients who have complications or symptoms, including persistent vaginal bleeding or discharge, pelvic or groin pain or pain with sex, should notify their health care professionals. Women who may have been planning a surgical mesh procedure should discuss other options with their doctors.
    Public Citizen, a consumer advocacy organization, petitioned for a ban against the mesh products in 2011 and then testified before an FDA advisory committee earlier this year, according to Dr. Michael Carome, director of the nonprofit's Health Research Group.
    Pregnancy is riskier than skydiving -- birth control should be harder to market